Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: uniQure N.V., 3 years.
uniQure N.V.
Director
Corbus Pharmaceuticals Holdings Inc.
Director
Akari Therapeutics plc
Director · Chief Executive Officer
Chief executive roles
Akari Therapeutics plc
· Chief Executive Officer
Since January 2024
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 19, 2024 | uniQure N.V. | Grant or award | +8,080 | — | — |
| Jun 13, 2024 | uniQure N.V. | Open-market sale | −2,221 | $5.14 | $11,416 |
| May 30, 2024 | Corbus Pharmaceuticals Holdings Inc. | Grant or award | +2,783 | — | — |
| Apr 26, 2024 | Akari Therapeutics plc | Grant or award | +479,569,892 | — | — |
| Jun 16, 2023 | uniQure N.V. | Open-market sale | −2,301 | $18.76 | $43,167 |
| Jun 13, 2023 | uniQure N.V. | Grant or award | +8,700 | — | — |
| Feb 27, 2023 | uniQure N.V. | Open-market sale | −384 | $20.02 | $7,688 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.